Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases

Objective: Ligustrazine is an amide alkaloid, with the active substance being Chuanxiong. Also known as tetramethylpyrazine (TMP), ligustrazine has various pharmacological effects and has been used to treat a variety of diseases. Many studies have demonstrated a role for ligustrazine in the treatmen...

Full description

Bibliographic Details
Main Authors: Yulu Hu, Ao Wang, Jie Chen, Hui Chen
Format: Article
Language:English
Published: IMR Press 2023-08-01
Series:Clinical and Experimental Obstetrics & Gynecology
Subjects:
Online Access:https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008164
_version_ 1797733128570142720
author Yulu Hu
Ao Wang
Jie Chen
Hui Chen
author_facet Yulu Hu
Ao Wang
Jie Chen
Hui Chen
author_sort Yulu Hu
collection DOAJ
description Objective: Ligustrazine is an amide alkaloid, with the active substance being Chuanxiong. Also known as tetramethylpyrazine (TMP), ligustrazine has various pharmacological effects and has been used to treat a variety of diseases. Many studies have demonstrated a role for ligustrazine in the treatment of several obstetrical and gynecological diseases. However, most results on the efficacy of ligustrazine have been obtained from basic laboratory experiments, with few clinical studies having validated these results. Mechanisms: In this narrative review we analyze the available literature summarizing the role and mechanism of ligustrazine in the treatment of obstetrical and gynecological diseases. Findings in Brief: TMP shows good results for the treatment of endometriosis, preeclampsia, ovarian cancer, as well as other obstetrical and gynecological diseases through its regulation of cell proliferation, invasion and metastasis, inflammation, immune response, apoptosis, autophagy, angiogenesis, endothelial protection, and fibrogenesis. Conclusions: TMP is therefore a promising drug with great research potential. Of note, ligustrazine is a complementary or alternative medicine and not the primary treatment. And most studies to date are laboratory-based experiments with low evidence levels. More in-depth research is needed to determine the pharmacological effects of ligustrazine in the clinic.
first_indexed 2024-03-12T12:23:41Z
format Article
id doaj.art-668df5b23e28499f9033e44237431ba9
institution Directory Open Access Journal
issn 0390-6663
language English
last_indexed 2024-03-12T12:23:41Z
publishDate 2023-08-01
publisher IMR Press
record_format Article
series Clinical and Experimental Obstetrics & Gynecology
spelling doaj.art-668df5b23e28499f9033e44237431ba92023-08-30T05:21:34ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632023-08-0150816410.31083/j.ceog5008164S0390-6663(23)02107-3Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological DiseasesYulu Hu0Ao Wang1Jie Chen2Hui Chen3Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaDepartment of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, 610041 Chengdu, Sichuan, ChinaObjective: Ligustrazine is an amide alkaloid, with the active substance being Chuanxiong. Also known as tetramethylpyrazine (TMP), ligustrazine has various pharmacological effects and has been used to treat a variety of diseases. Many studies have demonstrated a role for ligustrazine in the treatment of several obstetrical and gynecological diseases. However, most results on the efficacy of ligustrazine have been obtained from basic laboratory experiments, with few clinical studies having validated these results. Mechanisms: In this narrative review we analyze the available literature summarizing the role and mechanism of ligustrazine in the treatment of obstetrical and gynecological diseases. Findings in Brief: TMP shows good results for the treatment of endometriosis, preeclampsia, ovarian cancer, as well as other obstetrical and gynecological diseases through its regulation of cell proliferation, invasion and metastasis, inflammation, immune response, apoptosis, autophagy, angiogenesis, endothelial protection, and fibrogenesis. Conclusions: TMP is therefore a promising drug with great research potential. Of note, ligustrazine is a complementary or alternative medicine and not the primary treatment. And most studies to date are laboratory-based experiments with low evidence levels. More in-depth research is needed to determine the pharmacological effects of ligustrazine in the clinic.https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008164ligustrazinetetramethylpyrazinereviewpharmacologyobstetrical and gynecological diseases
spellingShingle Yulu Hu
Ao Wang
Jie Chen
Hui Chen
Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
Clinical and Experimental Obstetrics & Gynecology
ligustrazine
tetramethylpyrazine
review
pharmacology
obstetrical and gynecological diseases
title Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
title_full Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
title_fullStr Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
title_full_unstemmed Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
title_short Ligustrazine: A Review of Its Role and Mechanism in the Treatment of Obstetrical and Gynecological Diseases
title_sort ligustrazine a review of its role and mechanism in the treatment of obstetrical and gynecological diseases
topic ligustrazine
tetramethylpyrazine
review
pharmacology
obstetrical and gynecological diseases
url https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008164
work_keys_str_mv AT yuluhu ligustrazineareviewofitsroleandmechanisminthetreatmentofobstetricalandgynecologicaldiseases
AT aowang ligustrazineareviewofitsroleandmechanisminthetreatmentofobstetricalandgynecologicaldiseases
AT jiechen ligustrazineareviewofitsroleandmechanisminthetreatmentofobstetricalandgynecologicaldiseases
AT huichen ligustrazineareviewofitsroleandmechanisminthetreatmentofobstetricalandgynecologicaldiseases